Cubist Pharma waging a war against superbugs By: CNBC.com News December 16, 2013 at 12:49 PM EST Cubist Pharmaceuticals is focused on treatments for fighting superbugs, an area many drug developers are avoiding. But its success may attract their attention. Read More >> Related Stocks: Eli Lilly Fti Consulting Pfizer